04:48 AM EDT, 09/29/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Monday it plans a direct listing of its shares on the New York Stock Exchange, replacing the existing US listing of its American depositary receipts on Nasdaq.

The company's board recommended to its shareholders a "harmonized listing structure" for its shares across the London Stock Exchange, Nasdaq Stockholm and the NYSE, it said.

AstraZeneca ( AZN ) will remain headquartered in the UK.

The company's shares were up 1.1% in recent premarket activity.